Interestingly, TMPRSS2 is a directandrogen receptor target gene and its expression is increased by androgens in prostatecancer (61), which could also have an impact onTMPRSS2 expression in men with COVID-19. This evidence concerns the gene TMPRSS2 and COVID-19.